OMEGA THERAPEUTICS, INC.

(OMGA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2021 2022 2023 2024
Capitalization1 541109--
Enterprise Value (EV)1 33645,4-242-69,2
P/E ratio -3,71x-1,05x-0,86x-0,89x
Yield ----
Capitalization / Revenue 3 759x307x--
EV / Revenue 2 332x128x--
EV / EBITDA -5,20x-0,51x1,90x0,35x
Price to Book ----
Nbr of stocks (in thousands) 47 77547 848--
Reference price (USD) 11,32,282,282,28
Announcement Date 03/10/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023 2024
Net sales1 -0,140,36--
EBITDA1 --64,6-88,9-128-197
Operating profit (EBIT)1 --66,0-101-143-182
Operating Margin --45 856%-28 539%--
Pre-Tax Profit (EBT)1 --68,3-97,3-139-166
Net income1 -29,4-68,3-104-145-163
Net margin --47 417%-29 283%--
EPS2 -7,56-3,05-2,17-2,64-2,58
Dividend per Share -----
Announcement Date 07/09/202103/10/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 -0,140,270,050,050,05
EBITDA ------
Operating profit (EBIT)1 -17,2-20,7-20,0-24,7-27,1-29,8
Operating Margin --14 350%-7 447%-47 925%-52 557%-57 939%
Pre-Tax Profit (EBT)1 -18,5-20,9-20,2-22,9-25,6-28,7
Net income1 -18,5-20,9-20,2-25,6-28,1-30,2
Net margin --14 482%-7 524%-49 792%-54 633%-58 733%
EPS2 -0,57-0,44-0,42-0,54-0,59-0,63
Dividend per Share ------
Announcement Date 11/10/202103/10/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt1 -----
Net Cash position1 -20563,7351178
Leverage (Debt / EBITDA) -3,18x0,72x2,76x0,91x
Free Cash Flow1 --59,1-115-152-158
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex -----
Capex / Sales -----
Announcement Date 07/09/202103/10/2022---
1 USD in Million
Estimates
Key data
Capitalization (USD) 109 094 477
Net sales (USD) 144 000
Number of employees 80
Sales / Employee (USD) 1 800
Free-Float 96,3%
Free-Float capitalization (USD) 105 028 904
Avg. Exchange 20 sessions (USD) 378 654
Average Daily Capital Traded 0,35%
EPS & Dividend